Magnificent No More: TSLA’s Fallout + Tech’s Next Trend
In 2023, Tesla stock was riding high — leading the market as a member of the “Magnificent Seven.” But there's ...
by Adam O'Dell | Mar 26, 2024 | Money & Markets Daily
In 2023, Tesla stock was riding high — leading the market as a member of the “Magnificent Seven.” But there's ...
by Matthew Clark | Mar 18, 2024 | Money & Markets Daily
After a rough bear market, it looks like biotech stocks are charging higher. Here's a trend that points to more ...
by Michael Carr | Nov 29, 2023 | Money & Markets Daily
Trends in health care can become powerful tailwinds. Genomics is a good example of this. Here's how to find the ...
by Adam O'Dell | Oct 25, 2023 | Money & Markets Daily
For investors, seasonal patterns can be an extremely powerful tool. Here's how these trends have played out in the biotech ...
by Matthew Clark | Sep 4, 2023 | Money & Markets Daily
Novo Nordisk (NYSE: NVO) stock is rallying thanks to Ozempic, a diabetes drug that many are using for weight loss. ...
by Adam O'Dell | Jul 8, 2022 | Investing
Cathie Wood is one of the greatest investors of our time. Here's why we aren't worried her ARK Innovation ETF ...
by Adam O'Dell | Feb 21, 2022 | Investing
Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in ...
by Matthew Clark | Oct 23, 2021 | Markets, Podcast
Biotech is one of the fastest-growing markets today. ETFs are a great way for investors to get started in this ...
by Adam O'Dell | Oct 11, 2021 | Investing
The genomics and biotech revolution is here. Read this before you add a biotech IPO (initial public offering) to your ...
by Adam O'Dell | Sep 10, 2021 | Investing
Jeff Bezos is throwing money at a startup that is researching a way to reverse the aging process. Is genomics ...
Our experts do the work to make investing safe and profitable for you. Sign up for FREE access to our Money & Markets Daily daily emails and take control of the Markets!
Enter your username and password below